5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 18.20▼ | 18.07▲ | 18.07▲ | 17.92▲ | 17.85▲ |
MA10 | 18.12▲ | 18.02▲ | 18.01▲ | 17.65▲ | 18.24▼ |
MA20 | 18.02▲ | 18.08▲ | 18.06▲ | 17.82▲ | 19.06▼ |
MA50 | 18.08▲ | 17.91▲ | 17.77▲ | 18.27▼ | 17.42▲ |
MA100 | 17.98▲ | 17.74▲ | 17.84▲ | 19.23▼ | 13.98▲ |
MA200 | 17.76▲ | 17.93▲ | 18.22▼ | 17.85▲ | 12.31▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.027▲ | 0.002▲ | -0.006▼ | 0.080▲ | -0.269▼ |
RSI | 55.243▲ | 54.596▲ | 55.964▲ | 53.101▲ | 50.310▲ |
STOCH | 87.556▲ | 65.531 | 57.993 | 58.304 | 39.200 |
WILL %R | -24.000▲ | -24.000▲ | -41.837 | -18.116▲ | -69.675 |
CCI | 37.931 | 85.891 | 35.260 | 105.657▲ | -28.428 |
Wednesday, July 02, 2025 05:00 PM
ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that its Board of Directors declared cash dividends on its Preferred Stock. The most you can lose on any stock (assuming ...
|
Wednesday, May 14, 2025 01:26 PM
Potential Positives. Positive interim data from the ACR-368 Phase 2b study showed a confirmed overall response rate (cORR) of 35% in heavily pretreated endometrial cancer patients, highlighting ...
|
Friday, April 25, 2025 05:13 AM
Acrivon Therapeutics presents data on ACR-2316's tumor cell death mechanisms and early clinical trial results at AACR 2025. Quiver AI Summary. Acrivon Therapeutics has announced that it will ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 17.94 | 18.36 | 17.835 | 18.19 | 13,054 |
02/07/25 | 17.802 | 18.10 | 17.80 | 17.81 | 37,608 |
01/07/25 | 17.94 | 18.44 | 17.8901 | 18.04 | 51,283 |
30/06/25 | 17.58 | 18.09 | 17.53 | 17.94 | 55,814 |
27/06/25 | 17.33 | 17.79 | 17.22 | 17.64 | 817,200 |
26/06/25 | 17.39 | 17.52 | 17.17 | 17.24 | 44,500 |
25/06/25 | 17.83 | 17.89 | 17.25 | 17.25 | 38,700 |
24/06/25 | 17.31 | 17.91 | 17.31 | 17.83 | 43,100 |
23/06/25 | 17.27 | 17.70 | 17.06 | 17.25 | 60,100 |
20/06/25 | 17.82 | 17.98 | 17.28 | 17.29 | 92,700 |
|
|
||||
|
|
||||
|
|